These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21830280)

  • 1. Severe agranulocytosis following first infliximab infusion in Crohn's disease.
    Rosales-Zábal JM; Fernández-Pérez F; Albandea-Moreno C; Vera-Rivero FM; Navarro-Jarabo JM
    Inflamm Bowel Dis; 2011 Nov; 17(11):E147-8. PubMed ID: 21830280
    [No Abstract]   [Full Text] [Related]  

  • 2. Pericarditis as a complication of infliximab therapy in Crohn's disease.
    Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
    Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
    [No Abstract]   [Full Text] [Related]  

  • 3. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
    Mocciaro F; Russo G; Di Mitri R; Marino A
    Inflamm Bowel Dis; 2013; 19(4):E52-3. PubMed ID: 22535599
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease.
    Ritz MA; Jost R
    Inflamm Bowel Dis; 2001 Nov; 7(4):327. PubMed ID: 11720324
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
    Shanahan F
    Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
    Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
    [No Abstract]   [Full Text] [Related]  

  • 7. Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist.
    Angelucci E; Cocco A; Viscido A; Vernia P; Caprilli R
    Inflamm Bowel Dis; 2007 Aug; 13(8):1059-61. PubMed ID: 17387676
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab treatment for Crohn's disease.
    Conroy CA; Cattell R
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract]   [Full Text] [Related]  

  • 9. Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease.
    Panagi S; Palka W; Korelitz BI; Taskin M; Lessnau KD
    Inflamm Bowel Dis; 2004 May; 10(3):274-7. PubMed ID: 15290924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
    Bell S; Kamm MA
    Lancet; 2000 Mar; 355(9207):858-60. PubMed ID: 10752696
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
    Dubcenco E; Ottaway CA; Chen DL; Baker JP
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):565-6. PubMed ID: 16607158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody therapy for Crohn's disease.
    Selby W
    Intern Med J; 2001 Mar; 31(2):73-4. PubMed ID: 11480481
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
    Baert F; Noman M; Vermeire S; Van Assche G; D' Haens G; Carbonez A; Rutgeerts P
    N Engl J Med; 2003 Feb; 348(7):601-8. PubMed ID: 12584368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
    Martínez F; Nos P; Benlloch S; Ponce J
    Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
    Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
    Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing TB in patients with Crohn's disease needing infliximab or other anti-TNF therapy.
    Rampton DS
    Gut; 2005 Oct; 54(10):1360-2. PubMed ID: 16113045
    [No Abstract]   [Full Text] [Related]  

  • 17. [Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease].
    Osuna Molina R; Ferrer Ríos T; Gallego Gallegos R; Ramos Lora M; Ynfante Ferrús M; Figueruela López B
    Rev Esp Enferm Dig; 2006 Jan; 98(1):60-1. PubMed ID: 16555939
    [No Abstract]   [Full Text] [Related]  

  • 18. Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor.
    Wagner TE; Huseby ES; Huseby JS
    Am J Med; 2002 Jan; 112(1):67-9. PubMed ID: 11812409
    [No Abstract]   [Full Text] [Related]  

  • 19. Crohn's disease, infliximab and idiopathic thrombocytopenic purpura.
    Selby LA; Hess D; Shashidar H; de Villiers WJ; Selby LA
    Inflamm Bowel Dis; 2004 Sep; 10(5):698-700. PubMed ID: 15472539
    [No Abstract]   [Full Text] [Related]  

  • 20. Extensive forearm deep venous thrombosis following a severe infliximab infusion reaction.
    Ryan BM; Romberg M; Wolters F; Stockbrugger RW
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):941-2. PubMed ID: 15316423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.